| Size | 10 mg/50 mg |
| Purity | ≥98% |
| Formula | C25H23N7OS |
| Molecule Mass | 469.56 |
| Chemical Name | N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide |
| SMILES | O=C(NC=1C=CC=CC1C=2N=C3SC=C(N3C2)CN4CCNCC4)C5=NC6=CC=CC=C6N=C5 |
| Target | SIRT1 |
| Biological Activity | SRT 1720 is a selective activator of SIRT1, with an EC50 of 0.16 μM. It inhibits the growth of bladder cancer organoids and xenografts (IC50 = 0.35 μM) and induces autophagy. |
| Appearance | Solid |
| Color | Light yellow to yellow |
| Solubilization | The compound is soluble to 5 mM in DMSO |
| Storage | Store at -20°C |
| Shipping Information | Room temperature |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.